5th Annual Molecular Glue Drug Development Summit

5th Annual Molecular Glue Drug Development Summit is organized by Hanson Wade and will be held from Jan 26 - 28, 2027 at Hyatt Regency Boston Harbor, Boston, Massachusetts, United States of America.

Description:
Unlocking Novel Biology & Rational Design to Develop Potent, Selective & Safer Molecular Glues Cures Against Cancer & Beyond
From Revolution Medicines' landmark FDA approval of RASONQUE™ to major discovery partnerships such as the up to $1.4 billion Novartis-Orionis collaboration, molecular glues continue to generate momentum across both clinical development and early-stage innovation. Combined with rapid advances in artificial intelligence, automation, structural biology, and induced proximity therapeutics, the field is entering a new era of discovery, unlocking previously inaccessible biology and expanding the potential of molecular glues across a growing range of disease areas.

As investment, scientific understanding, and translational success accelerate, the 5th Molecular Glue Drug Development Summit serves as the industry's only dedicated forum bringing together the scientists and drug developers advancing molecular glue therapeutics from early discovery through translational and clinical development.

Explore the Full Event Guide:

• Get the complete agenda, speaker faculty, workshops, and networking opportunities in one place
• Explore the latest advances in molecular glue therapeutics, induced proximity biology, targeted protein degradation, and protein stabilization
• Discover how AI, computational modelling, automation, and structural biology are transforming rational glue discovery
• See which pharma, biotech, academic, and investment leaders are driving the next wave of proximity-based therapeutics
• Share with colleagues to evaluate scientific learnings, partnership opportunities, and commercial potential